A detailed history of Tennessee Valley Asset Management Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Tennessee Valley Asset Management Partners holds 23,969 shares of ABBV stock, worth $4.27 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
23,969
Previous 24,089 0.5%
Holding current value
$4.27 Million
Previous $4.13 Million 14.57%
% of portfolio
0.78%
Previous 0.78%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $19,660 - $23,919
-120 Reduced 0.5%
23,969 $4.73 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $11,609 - $13,557
75 Added 0.31%
24,089 $4.13 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $54,019 - $61,549
-338 Reduced 1.39%
24,014 $4.37 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $31,648 - $35,643
-230 Reduced 0.94%
24,352 $3.77 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $30,725 - $35,569
-230 Reduced 0.93%
24,582 $3.66 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $2,252 - $2,803
-17 Reduced 0.07%
24,812 $3.34 Million
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $8,531 - $9,825
-59 Reduced 0.24%
24,829 $3.96 Million
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $5,947 - $7,132
-43 Reduced 0.17%
24,888 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $2,147 - $2,462
16 Added 0.06%
24,931 $3.35 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $447,127 - $568,445
-3,249 Reduced 11.54%
24,915 $3.82 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $674,417 - $836,762
-5,110 Reduced 15.36%
28,164 $4.57 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $49,202 - $62,255
458 Added 1.4%
33,274 $4.51 Million
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $70,330 - $79,835
661 Added 2.06%
32,816 $3.54 Million
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $3.21 Million - $3.58 Million
-30,517 Reduced 48.69%
32,155 $4,000
Q1 2021

Apr 16, 2021

BUY
$102.3 - $112.62 $43,375 - $47,750
424 Added 0.68%
62,672 $6.78 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $2.5 Million - $3.38 Million
31,103 Added 99.87%
62,248 $6.67 Million
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $1.82 Million - $2.13 Million
21,156 Added 211.79%
31,145 $2.73 Million
Q2 2020

Nov 05, 2020

BUY
$73.37 - $98.18 $392,015 - $524,575
5,343 Added 115.0%
9,989 $981,000
Q1 2020

Nov 12, 2020

BUY
$64.5 - $97.79 $299,667 - $454,332
4,646 New
4,646 $354,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tennessee Valley Asset Management Partners Portfolio

Follow Tennessee Valley Asset Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tennessee Valley Asset Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Tennessee Valley Asset Management Partners with notifications on news.